Advanced ovarian clear cell carcinoma with RAD50 mutation treated by PARP inhibitor pamiparib combined with anti-angiogenesis therapy: a case report

Ovarian clear cell carcinoma (OCCC) is a relatively uncommon epithelial ovarian malignancy with unique clinical, histopathologic and genetic characteristics. Patients with advanced OCCC have poor outcomes and are resistant to standard chemotherapy. Targeted therapy offers a novel approach for treati...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaoyan, He, Xiaojian, Li, Dongliang, Chen, Xiong, Chen, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815817/
https://www.ncbi.nlm.nih.gov/pubmed/36729997
http://dx.doi.org/10.1097/CAD.0000000000001412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815817/
https://www.ncbi.nlm.nih.gov/pubmed/36729997
http://dx.doi.org/10.1097/CAD.0000000000001412

Ejemplares similares